The research progress of mesenchymal stem cells as the adjuvant therapy of multidrug-resistant tuberculosis

Rui-juan SONG,Feng LI,Shui-hua LU
DOI: https://doi.org/10.3969/j.issn.1000-6621.2017.03.019
2017-01-01
Abstract:Chemotherapy is the most important means for human to fight against tuberculosis in modern times.To a certain extent,anti-tuberculosis chemotherapy reduces the threat of tuberculosis to human beings.But with the prevalence of drug-resistant tuberculosis and the development of new drug slowly,anti-tuberculosis chemotherapy failed into a bottleneck.On the way of exploring anti-tuberculosis treatment in recent years,people gradually realized the importance of immunotherapy.The immunomodulation of mesenchymal stem cells (MSCs) in acute inflammation and bacterial pneumonia has been recognized.Several studies have indicated that MSCs may have the potential therapeutic effect for tuberculosis.In this article,the research progress of the adjuvant therapy multi-drug resistant tuberculosis (MDR-TB) of MSCs have been summarized.
What problem does this paper attempt to address?